HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.

Abstract
Pituitary adenylate cyclase activating popypeptide (PACAP) is a pleiotropic neuropeptide, exerting neurotrophic and neuroprotective effects in numerous models of in vitro and in vivo nervous injuries. The aim of the present study was to investigate whether PACAP is neuroprotective in ischemic retinal damage. Adult male Wistar rats underwent bilateral carotid occlusion and PACAP was administered unilaterally into the vitreous body immediately following carotid occlusion. Retinas were analyzed three weeks after the injury. It was found that bilateral carotid occlusion led to a severe degeneration of all retinal layers. PACAP treatment significantly ameliorated the carotid occlusion-induced retinal damage: the overall thickness of the retina was significantly more than in control carotid occluded animals and the morphological characteristics of the photoreceptors showed nearly normal appearance. The outer plexiform layer remained discernible and the inner and outer nuclear layers were significantly thicker than in control animals. In summary, our present study provides evidence, for the first time, that PACAP attenuates ischemic retinal degeneration.
AuthorsTamás Atlasz, Norbert Babai, Péter Kiss, Dóra Reglodi, Andrea Tamás, Krisztina Szabadfi, Gábor Tóth, Orsolya Hegyi, Andrea Lubics, Róbert Gábriel
JournalGeneral and comparative endocrinology (Gen Comp Endocrinol) 2007 Aug-Sep Vol. 153 Issue 1-3 Pg. 108-14 ISSN: 0016-6480 [Print] United States
PMID17289046 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuroprotective Agents
  • Pituitary Adenylate Cyclase-Activating Polypeptide
Topics
  • Animals
  • Carotid Artery Diseases (complications, pathology)
  • Instillation, Drug
  • Male
  • Neuroprotective Agents (therapeutic use)
  • Pituitary Adenylate Cyclase-Activating Polypeptide (administration & dosage, antagonists & inhibitors, therapeutic use)
  • Rats
  • Rats, Wistar
  • Retinal Diseases (etiology, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: